Bio-Rad Laboratories Profit Margin

Bio-Rad Laboratories posts a profit margin of 6.52% as of March 2026. That compares with -87.68% in the prior-year period — up 107.4% year over year. That is below the Healthcare sector average of 15.29%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Bio-Rad Laboratories's profit margin was -87.68%. The latest reading is 6.52% — a 107.4% year-over-year increase (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 15.29% is typical. Bio-Rad Laboratories's 6.52% is lower that level. That is roughly 57.4% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Bio-Rad Laboratories's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 6.52% as of March 2026; use YoY and peer views to separate noise from signal.

Context for BIO.B's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 15.29%), and (3) consistency with growth and profitability. This page covers the first two; Bio-Rad Laboratories's other metric pages and overview cover the third.